264 results
Page 2 of 14
8-K
EX-99
4wtcn2d2eavd
13 Dec 22
Lilly Announces 2023 Financial Guidance, Plans to Launch up to Four New Medicines
7:03am
8-K
EX-99.1
9ueq7p1noa cnneu
1 Nov 22
Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline Progress
7:03am
SC TO-T
EX-99
mieias mf4vx2hr
31 Oct 22
Third party tender offer statement
6:51am
8-K
EX-99.1
8s1rv08ci 33
4 Aug 22
Lilly Reports Second-Quarter Financial Results, Highlights Momentum of New Medicines and Pipeline Advancements
7:05am
8-K
EX-3.2
j9yibfa0eiq3gv793s2
4 May 22
Material Modifications to Rights of Security Holders
3:04pm
8-K
EX-99.1
ai218ha38aiyd
28 Apr 22
Solid First-Quarter Financial Results Reflect Lilly's Continued Momentum into 2022
7:05am
S-3ASR
i4mqg abjlfoxfucf4s
24 Feb 22
Automatic shelf registration
6:31am
8-K
EX-99.1
61yd5
3 Feb 22
Results of Operations and Financial Condition
7:08am
8-K
EX-3.1
ekrops1 567wgk
16 Dec 21
Amendments to Articles of Incorporation or Bylaws
4:04pm
8-K
EX-99.1
n3v3usq0hhr g3yyg
15 Dec 21
Lilly Highlights Innovation-based Growth Strategy and Pipeline Developments; Announces 2022 Financial Guidance at Investment Community Meeting
7:05am
8-K
EX-99.1
7fwjvmzhcg mc
26 Oct 21
Lilly Reports Robust Third-Quarter 2021 Financial Results
7:06am
424B2
57ezu5ig4wj1
10 Sep 21
Prospectus for primary offering
6:07am
424B2
rmgy5c0kdmsik
7 Sep 21
Prospectus for primary offering
6:02am